168 related articles for article (PubMed ID: 37855744)
1. Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13.
Chrisentery-Singleton T; Boggio LN; Carcao MD; Ibrahimi S; Khan O; Mahajerin A; Rajasekhar A; Sharma V; Steele M; Torres M; Rodino FJ; Carpenter SL
Haemophilia; 2023 Nov; 29(6):1638-1645. PubMed ID: 37855744
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.
Peyvandi F; Mannucci PM; Valsecchi C; Pontiggia S; Farina C; Retzios AD
Am J Hematol; 2013 Oct; 88(10):895-8. PubMed ID: 23813910
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.
Allford SL; Harrison P; Lawrie AS; Liesner R; MacKie IJ; Machin SJ
Br J Haematol; 2000 Dec; 111(4):1215-22. PubMed ID: 11167764
[TBL] [Abstract][Full Text] [Related]
5. Hereditary Thrombotic Thrombocytopenic Purpura.
Nusrat S; Beg K; Khan O; Sinha A; George J
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895305
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Congenital Thrombotic Thrombocytopenia Purpura: A New Paradigm.
Aledort LM; Singleton TC; Ulsh PJ
J Pediatr Hematol Oncol; 2017 Oct; 39(7):524-527. PubMed ID: 28737602
[TBL] [Abstract][Full Text] [Related]
7. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
Schiphorst RH; van de Kar NC; van den Heuvel LP
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
[TBL] [Abstract][Full Text] [Related]
9. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Lämmle B
Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
[TBL] [Abstract][Full Text] [Related]
10. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.
Kinoshita S; Yoshioka A; Park YD; Ishizashi H; Konno M; Funato M; Matsui T; Titani K; Yagi H; Matsumoto M; Fujimura Y
Int J Hematol; 2001 Jul; 74(1):101-8. PubMed ID: 11530798
[TBL] [Abstract][Full Text] [Related]
11. [Siblings with congenital thrombotic thrombocytopenic purpura].
Funakoshi Y; Okada M; Matsumoto M; Kokame K; Moriuchi H
Rinsho Ketsueki; 2017; 58(8):933-937. PubMed ID: 28883277
[TBL] [Abstract][Full Text] [Related]
12. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
Schneppenheim R; Budde U
Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
[TBL] [Abstract][Full Text] [Related]
13. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
Rank CU; Kremer Hovinga J; Taleghani MM; Lämmle B; Gøtze JP; Nielsen OJ
Eur J Haematol; 2014 Feb; 92(2):168-71. PubMed ID: 24033710
[TBL] [Abstract][Full Text] [Related]
14. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
15. Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): a short review.
Pérez-Rodríguez A; Lourés E; Rodríguez-Trillo Á; Costa-Pinto J; García-Rivero A; Batlle-López A; Batlle J; López-Fernández MF
Thromb Res; 2014 Dec; 134(6):1171-5. PubMed ID: 25242241
[TBL] [Abstract][Full Text] [Related]
16. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
Manea M; Karpman D
Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.
Loirat C; Veyradier A; Girma JP; Ribba AS; Meyer D
Semin Thromb Hemost; 2006 Mar; 32(2):90-7. PubMed ID: 16575683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
